PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2192
https://www.valueinhealthjournal.com/article/S1098-3015(12)03906-X/fulltext
Title : PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03906-X&doi=10.1016/j.jval.2012.08.2192
First page : A437
Section Title : Cancer
Open access? : No
Section Order : 844
Categories :
Tags :
Regions :
ViH Article Tags :